ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07643
-0,08%
Bitcoin
63.831,58
-0,10%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Crinetics Pharmaceuticals Inc (CRNX)

  7. Crinetics Pharmaceuticals Inc (CRNX) News

CRNX Crinetics Pharmaceuticals Inc

47,20
0,42 (0,90%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Crinetics Pharmaceuticals Inc CRNX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,42 0,90% 47,20 06:00:04
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
47,52 47,13 48,37 47,20 46,78
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.3.202421:15EDGAR2Form D - Notice of Exempt Offering of Securities
07.3.202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
28.2.202422:09EDGAR2Form 8-K - Current report
14.2.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202419:03EDGAR2Form 144 - Report of proposed sale of securities
12.1.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202418:10EDGAR2Form 144 - Report of proposed sale of securities
08.1.202414:03EDGAR2Form 8-K - Current report
04.1.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:11EDGAR2Form 144 - Report of proposed sale of securities
02.1.202422:44EDGAR2Form 144 - Report of proposed sale of securities
27.12.202323:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202317:47EDGAR2Form 144 - Report of proposed sale of securities
23.12.202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202323:28EDGAR2Form 144 - Report of proposed sale of securities
18.12.202322:12EDGAR2Form 8-K - Current report
13.12.202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:35EDGAR2Form 8-K - Current report
11.12.202319:48EDGAR2Form 144 - Report of proposed sale of securities
29.11.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202317:40EDGAR2Form 144 - Report of proposed sale of securities
13.11.202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.11.202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:04EDGAR2Form 8-K - Current report
07.11.202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.11.202300:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202321:00EDGAR2Form 144 - Report of proposed sale of securities
02.11.202321:02EDGAR2Form 144 - Report of proposed sale of securities
01.11.202321:44EDGAR2Form 144 - Report of proposed sale of securities
13.9.202323:23EDGAR2Form 8-K - Current report
13.9.202323:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11.9.202322:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11.9.202312:05EDGAR2Form 8-K - Current report
16.8.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202313:01EDGAR2Form 8-K - Current report
13.7.202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.7.202322:14EDGAR2Form 144 - Report of proposed sale of securities
12.7.202322:25EDGAR2Form 144 - Report of proposed sale of securities
11.7.202322:39EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
CRNX
Crinetics Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten